Japanese pharmaceutical company From Wikipedia, the free encyclopedia
Remove ads
Shionogi & Company, Limited (塩野義製薬株式会社, Shionogi Seiyaku Kabushiki Kaisha) is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).
You can help expand this article with text translated from the corresponding article in Japanese. (January 2025) Click [show] for important translation instructions.
View a machine-translated version of the Japanese article.
Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Consider adding a topic to this template: there are already 1,306 articles in the main category, and specifying|topic= will aid in categorization.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Japanese Wikipedia article at [[:ja:塩野義製薬]]; see its history for attribution.
You may also add the template {{Translated|ja|塩野義製薬}} to the talk page.
Shionogi has business roots that date back to 1878, and was incorporated in 1919. Among the medicines produced are for hyperlipidaemia, antibiotics, and cancer medicines.
In Japan it is particularly known as a producer of antimicrobial and antibiotics. Because of antibiotic resistance and slow growth of the antibiotic market, it has teamed up with US based Schering-Plough (merged in 2009 with Merck & Co) to become a sole marketing agent for its products in Japan.
Shionogi had supported the initial formation of Ranbaxy Pharmaceuticals, a generic manufacturer based in India. In 2012 the company became a partial owner of ViiV Healthcare, a pharmaceutical company specialising in the development of therapies for HIV.[4]
Asapiprant[Wikidata] (BGE-175), a DP1 receptor antagonist under development for treatment of COVID-19 in elderly patients and allergic rhinitis.[11][12][13][14][15]
Remove ads
Media
Shionogi (and later Shinonogi Healthcare) has been the sponsor of Fuji Television Network, Inc.'s "Music Fair" since it started in 1964. In January 2025, Shionogi has decided to remove its name from the show, due to the Fuji TV - Masahiro Nakai scandal. A Shionogi representative said in an interview, "I believe that Fuji Television should provide an explanation of the facts and future actions as soon as possible".[16][17]
Shionogi was a main sponsor of Team Lotus in the team's final years between 1991 and 1994.[18]
